Violeta Temper
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Bacterial Infections and Vaccines
- Medical Device Sterilization and Disinfection
Papers in
-
- Antibiotic Resistance in Bacteria 9
-
- Bacterial Infections and Vaccines 4
- Co-authors
- Colin Block (8 shared papers)Allon E. Moses (5 shared papers)Amos Adler (3 shared papers)Carlos Hidalgo‐Grass (6 shared papers)Jacob Strahilevitz (9 shared papers)Shmuel Benenson (6 shared papers)Diana Averbuch (6 shared papers)Johanna Emgård (1 shared paper)
- Journals
- Emerging infectious diseases (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Medical Microbiology (2 papers)Clinical Infectious Diseases (1 paper)Vaccine (1 paper)
- Partner nations
- IsraelGermanyUnited States
In The Last Decade
Violeta Temper
30 papers receiving 502 citations
Peers
Comparison fields: 5 of 65
- Molecular Medicine 106
- Microbiology 60
- Infectious Diseases 94
- Clinical Biochemistry 18
- Endocrinology 15
Countries citing papers authored by Violeta Temper
This map shows the geographic impact of Violeta Temper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Temper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Temper more than expected).
Fields of papers citing papers by Violeta Temper
This network shows the impact of papers produced by Violeta Temper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Temper. The network helps show where Violeta Temper may publish in the future.
Co-authors
The 25 scholars most cited alongside Violeta Temper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 61 | |
| 2 | 2015 | 57 | |
| 3 | 2019 | 56 | |
| 4 | 2007 | 45 | |
| 5 | 2010 | 43 | |
| 6 | 2006 | 36 | |
| 7 | 2008 | 24 | |
| 8 | 2012 | 24 | |
| 9 | 2012 | 24 | |
| 10 | 2010 | 20 | |
| 11 | 2019 | 19 | |
| 12 | 2009 | 17 | |
| 13 | 2015 | 16 | |
| 14 | 2011 | 12 | |
| 15 | 2024 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 8 | |
| 19 | 2020 | 6 | |
| 20 | 2024 | 5 |
About Violeta Temper
Violeta Temper is a scholar working on Molecular Medicine, Microbiology, Infectious Diseases, Parasitology and Epidemiology, having authored 31 papers that have together received 525 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Bacterial Infections and Vaccines (4 papers), Burkholderia infections and melioidosis (3 papers), Infection Control in Healthcare (3 papers), Antifungal resistance and susceptibility (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Aquatic Ecosystems and Phytoplankton Dynamics (1 paper) and Infections and bacterial resistance (1 paper). The work is most often cited by research in Molecular Medicine (106 citations), Microbiology (60 citations), Infectious Diseases (94 citations), Clinical Biochemistry (18 citations) and Endocrinology (15 citations). Violeta Temper has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Colin Block, Allon E. Moses, Amos Adler, Carlos Hidalgo‐Grass, Jacob Strahilevitz, Shmuel Benenson, Diana Averbuch, Johanna Emgård, Ofer Mandelboim and Gilad Bachrach. Their work appears in journals such as Emerging infectious diseases, Antimicrobial Agents and Chemotherapy, Journal of Medical Microbiology, Clinical Infectious Diseases and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.